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Purpose: Benzalkonium chloride (BAK), the most commonly used preservative in eye drops, is known to induce ocular
irritation symptoms and dry eye in long-term treated patients and animal models. As tear film hyperosmolarity is diagnostic
of some types of dry eye disease, we determined in vitro on conjunctival epithelial cells the cytoxicity of BAK in
hyperosmolar conditions through cell viability, apoptosis, and oxidative stress assays.
Methods: The Wong Kilbourne derivative of Chang conjunctival epithelial cells were cultured for 24 h or 48 h either in
NaCl-induced hyperosmolar conditions (400–425–500 mOsM), in low concentrations of BAK (10−4%, 3.10−4%, and
5.10−4%), or in combination of both. We investigated cell viability through lysosomal integrity evaluation, cell death (cell
membrane permeability and chromatin condensation), and oxidative stress (reactive oxygen species, superoxide anion)
using  spectrofluorimetry.  Immunohistochemistry  was  performed  for  cytoskeleton  shrinkage  (phalloidin  staining),
mitochondrial permeability transition pore (cytochrome c release), the apoptosis effector active caspase-3, and the caspase-
independent  apoptosis  factor  AIF.  We  also  observed  early  effects  induced  by  the  experimental  conditions  on  the
conjunctival cell layers using phase contrast imaging of live cells.
Results: As compared to standard culture solutions, hyperosmolar stress potentiated BAK cytotoxicity on conjunctival
cells through the induction of oxidative stress; reduction of cell viability; cell membrane permeability increase; cell
shrinkage with cell blebbing, as shown in phase contrast imaging of live cells; and chromatin condensation. Like BAK,
but to a much lesser extent, hyperosmolarity increased cell death in a concentration-dependent manner through a caspase-
dependent apoptosis characterized by a release of cytochrome c in the cytoplasm from mitochondria and the activation of
caspase-3. Moreover, the caspase-independent apoptosis factor AIF was found translocated from mitochondria to the
nucleus in both conditions.
Conclusions: This study showed increased cytotoxic effects of BAK in hyperosmotic conditions, with characteristic cell
death processes, namely caspase-dependent and independent apoptosis and oxidative stress. As BAK is known to disrupt
tear film, which could promote evaporative dry eye and tear hyperosmolarity, BAK could promote the conditions
enhancing its own cytotoxicity. This in vitro hyperosmolarity model thus highlights the risk of inducing a vicious cycle
and the importance of avoiding BAK in patients with dry eye conditions.
The ocular surface is the most environmentally exposed
mucosal surface of the body, protected only by the lids and
tear film. The production and turnover of the tear functional
unit are essential for maintaining the ocular surface in good
health and efficiently preventing foreign particles, pathogens,
allergens, or irritants from entering or injuring the eye. Dry
eye is a multifactorial worldwide syndrome affecting one
million people, with a prevalence in the general population
over 50 years of 3%–15% [1]. Dry eye is characterized by eye
irritation symptoms, blurred and fluctuating vision, tear film
instability,  increased  tear  osmolarity,  and  impairment  of
ocular surface epithelia [2-4]. Dry eye symptoms result from
a poorly lubricated ocular surface inducing inflammation and
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cell apoptosis. Tear hyperosmolarity and inflammation of the
ocular  surface  epithelium  are  now  considered  the  core
mechanisms underlying dry eye disease and causing a vicious
cycle in which an abnormal tear film stimulates a series of
biologic events that further impair tear function [1,5]. In these
conditions, the ocular surface’s ability to maintain tear film
integrity and respond to environmental (indoor and outdoor
pollutants,  dust  particles,  pollens)  and  iatrogenic  (topical
ocular drugs and preservatives) challenges is impaired.
To understand the mechanisms leading to or induced by
dry  eye  disease,  many  experimental  models  have  been
developed in animals and cell lines. Mice, rats, rabbits, and
even dogs have been investigated [6-15]. Primary cultures of
corneal epithelial cells [16,17] or limbal cells [18] and corneal
cell  lines  [19,20]  have  been  extensively  studied  in
hyperosmolarity  conditions  to  evaluate  apoptosis  and
signaling pathways [18-23]. Hyperosmolarity was shown to
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851induce apoptosis in vitro on corneal or limbal cells through
mitochondrial depolarization, cytochrome c release, and an
increase in caspase 3/7 and 9 activity, confirming a caspase-
dependent  mechanism  [24,25].  Little  is  known,  however,
about  conjunctival  epithelium  behavior  in  hyperosmolar
conditions, even if a few studies have investigated the ocular
surface tissues more extensively.
Xiong  et  al.  [26]  and  Lin  et  al.  [27]  successfully
developed  in  vivo  dry  eye  models  in  rabbits  and  mice,
respectively,  using  topical  instillations  of  benzalkonium
chloride  (BAK).  BAK  is  the  most  commonly  used
preservative  in  eyedrops  and  is  known  for  its  toxic  and
proapoptotic effects on the ocular surface [28-31]. BAK is a
quaternary ammonium presenting tensioactive properties that
may disrupt the lipid layer of the tear film, thus increasing tear
evaporation  and  causing  tear  film  instability  [32].
Additionally, it was shown to destroy goblet cells [33,34] and
may directly play a role in iatrogenic dry eye development.
Moreover,  BAK  was  widely  suspected  of  being  the  most
important factor causing dry eye in glaucoma patients treated
over  a  long-term  [35-42],  a  concept  that  is  now  clearly
supported by the use of BAK as an inducer of dry eye in
experimental models. These findings directly demonstrate the
interactions between tear film, the ocular surface, and BAK,
through possible interactions with hyperosmotic stress and
inflammatory conditions, and thus show that BAK is a reliable
dry eye model.
The  aim  of  the  present  study  was  to  investigate  the
relationships  between  hyperosmolarity  and  BAK  in  vitro
through their respective and combined proapoptotic and pro-
oxidative effects on conjunctival epithelial cells, to determine
whether BAK toxicity would be enhanced in hyperosmotic
conditions, mimicking a frequent clinical condition in which
dry  eye  patients  receive  artificial  tears  preserved  with  a
chemical compound that may both promote and be potentiated
by tear hyperosmolarity.
METHODS
Cell  line:  The  Wong  Kilbourne  derivative  of  Chang
conjunctival  epithelial  cell  line  (WKD;  clone  1–5c-4,
American Type Culture Collection [ATCC, Manassas, VA]
certified cell line [CCL], 20.2) was cultured under standard
conditions (moist atmosphere, 5% CO2, 37 °C) in Dulbecco
minimum essential medium (DMEM, 340 mOsM±20 mOsM)
supplemented  with  10%  fetal  bovine  serum  (FBS),  1%
glutamine (200 mM stock solution), and 1% penicillin (10,000
units/ml) and streptomycin (10,000 µg/ml) for 24h to reach
confluence before challenges. This cell line has been used
previously  for  toxicological  in  vitro  studies  despite  the
presence of a small amount of HeLa cells. A toxicological
study aimed at comparing Wong Kilbourne cell line and IOBA
conjunctival  cell  line  confirmed  that  the  two  cell  lines
presented the same toxic responses [28,29,43].
All  reagents  were  purchased  from  Gibco  (Cergy
Pontoise, France).
Cell challenge conditions: At confluence, cells were grown
for 24 or 48 h: (1) in hyperosmolar media defined by different
osmolarities, assessed using an osmometer (Roebling 13DR,
Berlin, Germany), in accordance with previous studies [17,
18,20], ranging from standard conditions at 340 (iso-osmolar
culture medium), to 430, 450, or 500 mOsM, achieved by
adding  50,  60,  or  90  mM  sodium  chloride  (NaCl,  Fluka,
Buchs, Switzerland) in supplemented DMEM medium, called
HO50 mM, HO60 mM, and HO90 mM, respectively; (2) in
media containing BAK (Fluka) at 10−4%, 3.10−4%, or 5.10−4%
(345  mOsM±5  mOsM);  or  (3)  in  a  combination  of
hyperosmolarity  and  BAK,  by  crossing  the  three  osmotic
stresses with the three BAK concentrations.
Phase contrast imaging of live cells: Cells were cultured for
24 h on 0.17-mm-diameter Delta TPG uncoated culture dishes
(O420041500C; Bioptechs, Butler, NJ), then monitored at the
microscope stage (Eclipse 80i; Nikon, Tokyo, Japan) every 5
s with a charge-coupled device (CCD) camera (ORCA-03G;
Hamamatsu,  Hamamatsu,  Japan).  Videos  highlighted
morphological  changes  of  cell-size  decrease,  membrane
blebbing, formation of apoptotic bodies, and cell detachment.
Cells were first observed in 1 ml DMEM before being exposed
for  96  s  to  the  most  challenging  stresses,  HO90  mM,
BAK10−2%,  and  a  combination  of  HO90  mM  and
BAK10−2%, by adding 100 µl of HO900 mM, BAK10−1%, and
HO900 mM associated with BAK10−1% solutions.
Spectrofluorimetric  cytotoxicity  assays:  Cells  were  first
seeded at 105 cells/ml in 96-well microplates (Corning-Costar,
Corning, NY) for 24 h incubation to reach confluence in
standard  medium  before  cell  challenges  for  24–48  h  in
hyperosmolar  or  toxic  conditions.  The  neutral  red  uptake
(NRU),  YO-PRO-1,  Hoechst  33342,  2,7-
dichlorodihydrofluorescein  diacetate  (H2DCF-DA),  and
dihydroethidine  (HE)  assay  methods  were  previously
described and will be briefly explained [28]. Fluorescence was
measured using a microplate fluorometer (Infinite M1000;
Tecan, Lyon, France).
NRU/cell viability (CV) assay: Viable cells incorporate NR
(Fluka), a cationic dye that diffuses through the cell membrane
to  bind  the  lysosomal  matrix.  This  lysosomal  membrane
integrity is correlated with CV. After challenges, cells were
incubated in 200 µl of 50 µg/ml NR in DMEM for 3 h in
standard  conditions,  washed  in  PBS  (D-PBS  1×;  Gibco),
incubated for 15 min in a lysis solution (1% acetic acid/50%
ethanol/49% H2O) under agitation, and then fluorescence was
measured (excitation, 535 nm; emission, 600 nm).
Plasma-membrane  permeability  (PMP)/apoptosis
evaluation:  YO-PRO-1  (Fluka)  binds  DNA  after  opening
specific membrane pore P2X7 (purinergic receptor) activated
during  early  apoptosis  through  extracellular  ATP  (ATP)
[44], making it a cell membrane permeabilization marker.
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852After  challenges,  200  µl/well  of  a  2  µM  (1.26  mg/ml)
YOPRO-1 solution in PBS was added for 10 min at room
temperature (RT), in the dark before fluorometry analysis
(excitation, 491 nm; emission, 509 nm).
Caspase-3  activation  assessment/apoptosis  evaluation:
Caspase-3  activation  was  detected  using  the  Fluorometric
Assay  Kit  following  the  manufacturer’s  instructions
(Biovision, Mountain View, CA). Absorbance from cells with
and  without  24  h  treatment  was  compared  to  determine
relative caspase activation.
Chromatin  condensation  assessment/apoptosis  evaluation:
Hoechst 33342 (Invitrogen) is a UV fluorescent probe used to
evaluate cell chromatin condensation entering both apoptotic
and living cells. PI is used to discriminate necrotic cells since
this dye competes with Hoechst for binding to DNA. After
challenges, 200 µl of a solution containing Hoechst 33342
(0.5 µg/ml) and PI (0.05 µg/ml) in PBS was added for a 30
min incubation at RT, in the dark before fluorometry analysis
(excitation, 360 nm; emission, 450 nm).
Oxidative  stress  evaluation/H2DCF-DA  and  HE  assays:
Oxidative  stress  was  assessed  by  reactive  oxygen  species
(ROS) evaluation. Two different fluorometric methods were
used:  H2DCF-DA  (Interchim,  Montluçon,  France)  detects
hydroperoxide in cells (excitation, 490 nm; emission, 535
nm), whereas HE (Interchim) detects superoxide anion in
viable  cells  (excitation,  490  nm;  emission,  600  nm)
distinguishing O2.− from H2O2. After challenges, 200 µl of a
5 µM (1.58 µg/ml) HE solution in PBS or a 20 µM (9.75 µg/
ml) H2DCF-DA solution was added for a 20 min incubation
at 37 °C in moist atmosphere with 5% CO2 before fluorometry
analysis.
Apoptosis  immunodetection:&Dspase-dependentDndLQ
dependent apoptosis  was explored by highlighting specific
markers  (cytochrome  c  release,  active  caspase-3,  and
apoptosis-inducing  factor,  AIF,  respectively).  Cells  were
grown  on  round  sterile  cover  glasses  (diameter,  14  mm;
Menzel  GmbH,  Germany),  washed,  fixed  in  4%
paraformaldehyde-PBS, and permeabilized in 0.3% Triton
X-100  (Sigma-Aldrich,  Saint-Quentin  Fallavier,  France).
This  was  followed  by  a  1%  BSA  (BSA,  Sigma-Aldrich)
incubation for 30 min and a 1 h staining with the primary
antibodies against AIF, cytochrome c (1:100; Sigma-Aldrich),
and active caspase-3 (1:100; BDPharmingen, Franklin Lakes,
NJ). The cells were then incubated for 1 with the secondary
antibody Alexa Fluor® 488 (1:500, goat anti-rabbit and anti-
sheep;  Molecular  Probes,  Invitrogen)  before  a  30  min
incubation  with  phalloidin  (1:40,  Alexa  Fluor®  546;
Invitrogen) and a 15 min incubation with DAPI (1:2,000;
Sigma-Aldrich).  Cover  glasses  were  then  mounted  with
Mountant  PermaFluor®  (Thermo  Fisher  Scientific,
Courtaboeuf,  France)  before  observation  with  an
epifluorescence  microscope  (Leica  DM6000B,  Rueil-
Malmaison, France).
Statistical  analyses:  All  experiments  were  performed  in
triplicate,  and  the  groups  were  compared  using  one-way
ANOVA (ANOVA) followed by the Bonferroni adjustment
(GraphPad, GraphPad Software, La Jolla, CA).
RESULTS
Phase contrast video: WKD cells exhibited morphological
changes (Figure 1) with a cell-size decrease (Figure 1A), cell
blebs (Figure 1B), and cell detachment (Figure 1C) after the
different  stresses.  Under  hyperosmolar  conditions,  cells
exhibited a reversible cell-size decrease for 3 s after stress
before returning to normal cell size (at t=20 s); no visible
changes  were  observed  until  t=31  s,  then  a  very  discreet
cytoplasmic retraction was observed. Under BAK, stress cells
took longer to respond and showed irreversible morphological
changes (cytoplasm retraction visible from t=2–60 s and cell
blebs from t=60 s) leading to cell death at t=96 s, whereas
imposing both stresses induced irreversible cell death at
W s.
Spectrofluorimetric  cytotoxicity  assays:  These  assays  are
illustrated in Figure 2, Figure 3, Figure 4, Figure 5, Figure 6,
and  Figure  7  with  histograms  grouped  in  threes  after  the
control DMEM normalized at 100%, to show the respective
effects  of  (1)  HO  conditions,  (2)  BAK  conditions,  and
combinations of: (3) HO50 mM with BAK10−4%, 3.10−4%,
5.10−4%; (4) HO60 mM with BAK10−4%, 3.10−4%, 5.10−4%;
and (5) HO90 mM with BAK10−4%, 3.10−4%, 5.10−4%.
Neutral red/cell viability assay (Figure 2): Cell viability was
assessed at 24 h and 48 h following different challenges,
hyperosmolarity,  BAK  and  the  associations  of  both
conditions.
At 24 h, compared to DMEM, incubations in HO, BAK,
and combinations induced a CV decrease (p<0.001), except
for  BAK10−4%,  which  induced  a  slight  CV  increase
(p<0.001). Incubation with BAK3.10−4% or BAK5.10−4% for
24 h decreased CV compared to DMEM (p<0.001). Whatever
the concentration tested, BAK always decreased CV more
than any HO condition alone. In HO associated with BAK,
CV was further reduced compared to BAK alone, causing a
significant  cytotoxicity  dependent  on  both  HO  and  BAK
concentrations.  All  BAK10−4%  combinations  were
significantly  more  cytotoxic  (p<0.001)  than  BAK10−4%
alone. BAK3.10−4% combinations with HO50 mM, HO60
mM,  or  HO90  mM  were  significantly  more  cytotoxic
(p<0.001)  than  BAK3.10−4%  alone  (p<0.001),  but
BAK5.10−4% combinations with all HO combinations did not
differ from BAK5.10−4%, which was too cytotoxic for an
additive effect to be observed.
At 48 h, with a similar cytotoxicity profile, incubation in
the same conditions (HO, BAK, and combinations) further
induced a time-dependent CV decrease compared to 24 h. All
combinations induced additive effects (p<0.001) compared to
BAK solutions except for BAK 5.10−4% combinations with
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853HO60 mM and HO90 mM. All conditions were statistically
different (p<0.001) from the 100% DMEM control.
Plasma-membrane  permeability  (YO-PRO-1  assay)/
apoptosis  evaluation  (Figure  3):  We  assessed  apoptosis
pathway at 24 h and 48 h using PMP assay in our experimental
conditions, hyperosmolarity, BAK, and the associations of
both.
At 24 h, compared to DMEM, incubation for 24 h in HO,
BAK, and combinations induced a PMP increase (p<0.001),
except  for  HO50  mM  and  BAK10−4%,  which  induced  a
nonsignificant  increase.  Combinations  of  all  BAK
concentrations with HO solutions were statistically different
(p<0.001) from their respective BAK concentrations alone,
except for BAK5.10−4% combinations, in which no further
cytotoxicity could be observed compared to BAK5.10−4%
alone.
At 48 h, incubations in the same conditions (HO, BAK,
and combinations) induced a time-dependent increase in YO-
PRO-1  incorporation  compared  to  24  h.  Combinations  of
BAK3.104% and BAK5.10−4% with all HO did not differ from
the respective BAK solutions, as cytotoxicity was too high
and  the  stress  alone  could  not  be  distinguished  from  its
combinations. All conditions differed (p<0.001) from isotonic
DMEM  except  for  BAK  10−4%,  which  still  induced  a
nonsignificant increase at 48 h.
Caspase-3 activation/apoptosis evaluation (Figure 4): We
evaluated the involvement of caspase-3 activation at 24 h to
Figure 1. Phase contrast imaging of WKD live cells in DMEM (t=0 s) stressed at t=2 s by complementing media to obtain final concentration
of HO90 mM (A; animation1), BAK10−2% (B: animation 2), and HO90 mM+BAK10−2% (C; animation3). First line: HO90 mM at t=0 s, t=5
s, and t=60 s; HO90 mM stress induced a cell-volume decrease for 3 s after stress observed at t=5 s before returning to almost normal size
( t=31 s), then a very discreet cytoplasmic retraction was observed. Second line: BAK10−2% at t=0 s, t=60 s, and t=96s ; BAK induced a
progressive cytoplasm shrinkage observed from t=3 s to t=60 s (circles) and followed by intense cell blebbing (arrows, from t=60 s) before
cell death. Last line: HO90 mM+BAK10−2% at t=0 s, t=7 s, and t=31 s. Cells exhibited profound alteration just after stress, such as disruption
of plasma membrane and nuclear fragmentation leading to irreversible cell death already visible at t=7 s.
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stimulated by our different challenge.
HO90mM,  BAK3.10−4%,  and  combination  of
BAK3.10−4% with HO90 mM induced an increase (p<0.01)
in caspase 3 activity of 1.99×, 3.17×, and 9.00×, respectively,
compared to control.
Chromatin  condensation  (Hoechst  33342)/apoptosis
evaluation (Figure 5): A late apoptosis process was evaluated
at 24 h and 48 h using Hoechst 33342 to better-characterized
apoptosis following different challenges, hyperosmolar, BAK
and the association of both conditions.
At 24 h, compared to DMEM, incubations with HO,
BAK, and combinations induced an increase (p<0.001) in
fluorescence  levels  except  for  HO50  mM,  BAK10−4%,
BAK3.10−4%, and for combinations of BAK10−4% in HO
conditions.  No  combinations  of  BAK3.10−4%  and
BAK5.10−4% with HO50 mM, HO60 mM, and HO90 mM
differed.
Figure 2. Cell viability (neutral red uptake assay) at 24 h (gray bars) and 48 h (black bars). The results were expressed as percentages (means
±SD) of the 100% of control DMEM. When compared to DMEM, significant cytotoxic effects (p<0.001) were observed in HO conditions in
an HO-dependent manner, and in BAK solutions in a BAK concentration- and time-dependent manner after 24 h and 48 h, except for the
lowest concentration of BAK10−4%; the associations of both stresses in all experiments were more cytotoxic than their respective HO or
BAK conditions. The following letter codes were used for statistical comparisons with (b) all BAK concentrations, (b1) BAK10−4%, (b3)
BAK5.10−4%, (b5) BAK3.10−4%, (h) all HO solutions, (h50) HO50 mM, (h60) HO60 mM, (h90) HO90 mM, corresponding to a statistically
significant difference at p<0.001.
Figure 3. Plasma-membrane permeability (YO-PRO-1 assay) at 24 h (gray bars) and 48 h (black bars). The results expressed as percentages
(means±SD) of the 100% of control DMEM and signals emitted by cell population are reported over the neutral red test as an indication of
viable cells. At 24 h and 48 h, incubation in HO60 mM, HO90 mM, BAK3.10−4%,  BAK5.10−4% and combinations of BAK with all HO
conditions induced an increase (p<0.001) in plasma-membrane permeability compared to control. Combinations of BAK10-4% with all HO
increased detection level (p<0.001) compared to BAK10-4% alone. The following letter codes were used for statistical comparisons with (b)
all BAK concentrations, (b1) BAK10−4%, (b3) BAK5.10−4%, (b5) BAK3.10−4%, (h) all HO solutions, (h50) HO50 mM, (h60) HO60 mM,
(h90) HO90 mM, corresponding to a statistically significant difference at p<0.001.
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and combinations) induced a further increase in chromatin
condensation compared to 24 h, higher in presence of BAK,
and in associations with BAK than with HO solutions alone.
All  conditions  differed  (p<0.001)  from  DMEM  for  HO
conditions except with BAK10−4%, BAK10−4% with HO50
mM, and HO60mM, which induced a nonsignificant increase
in  chromatin  condensation  at  48  h.  No  BAK5.10−4%
combinations differed from the BAK solution alone because
it was already too toxic for further toxicity to be observed at
48 h.
Oxidative stress: As BAK is known as an inducer of oxidative
stress, we wanted to evaluate at 24 h and 48 h the effects of
hyperosmolarity alone and its association with BAK on this
production.
Superoxide anion evaluation (hydroethidine assay, Figure 6):
Incubations  for  24  h  and  48  h  induced  a  time-dependent
increase of fluorescence. Compared to control, 24 h and 48 h
incubations  in  HO60  mM,  HO90  mM,  BAK5.10−4%,  the
combination of any HO with BAK3.10−4% or BAK5.10−4%
induced a superoxide anion increase, BAK3.10−4% showing
an increase only at 48 h (p<0.001). At 48 h, all HO conditions
combined with BAK3.10−4% or BAK5.10−4% differed from
their respective BAK and HO conditions (p<0.001), except
for BAK5.10−4% combined with HO90 mM, which did not
differ from BAK5.10−4%.
ROS production (H2DCF-DA assay, Figure 7): Incubations
for 24 h and 48 h induced a time-dependent fluorescence
increase, higher at 48 h except for BAK5.10−4% with HO60
mM. At 24 h and 48 h, compared to control, incubation in
BAK5.10−4%  and  the  combination  of  any  HO  with
Figure 4. Capase-3 activity. HO90mM,
BAK3.10−4%,  and  HO90  mM
+BAK3.10−4%  induced  at  24  h  an
increase  of  caspase-3  activity  with
respective  levels  of  9458.3±1461.3,
15010.5±3947.8,  and  42688.7+/
−1142.7  compared  to  DMEM
(4742.4±1406.2; star  is   p<0.01).  The
combination  of  BAK3.10−4%  with
HO90  mM  induced  considerable
caspase-3 activity compared to HO90
mM and BAK3.10−4% alone (p<0.01).
Figure 5. Chromatin condensation (Hoechst 33342 assay) at 24 h (gray bars) and 48 h (black bars). The results expressed as percentages
(means±SD) of the 100% of control DMEM and signals emitted by cell population are reported over the neutral red test as an indication of
viable cells. At 24 h and 48h, incubations with HO, BAK and all combinations induced an increase (p<0.001) in fluorescence levels compared
to control (except at 24 h for HO50 mM, BAK10−4% and combinations of BAK10−4% with all HO). All combinations of BAK3.10−4%
with  HO  were  statistically  different  (p<0.001)  compared  to  BAK3.10-4%  alone.  The  following  letter  codes  were  used  for  statistical
comparisons with (b) all BAK concentrations, (b1) BAK10−4%, (b3) BAK5.10−4%, (b5) BAK3.10−4%, (h) all HO solutions, (h50) HO50
mM, (h60) HO60 mM, (h90) HO90 mM, corresponding to a statistically significant difference at p<0.001.
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increase (p<0.001), except for HO50 mM and HO60 mM
associated with BAK3.10−4% at 24 h. HO combinations with
BAK3.10−4% or BAK5.10−4% were more cytotoxic (p<0.001)
than their respective BAK and HO conditions, except for
HO50 mM associated with BAK3.10−4% at 24 h where there
was no difference from BAK3.10−4%. BAK10−4% alone or
combined with HO did not differ from DMEM.
Immunofluorescence microscopy/apoptosis immunodetection
(Figure 8 and Figure 9): Hyperosmolarity, BAK, and both
challenges combined induced caspase-dependent apoptosis.
Cytochrome c was released from mitochondria (Figure 8A-D)
to  the  cytoplasm  and  an  increased  expression  of  active
caspase-3 was also observed in the cytoplasm of cells stressed
by hyperosmolarity, BAK, and combinations (Figure 8E-H).
Both stresses also stimulated caspase-independent apoptosis
through AIF release from the mitochondrial inner membrane
to the nucleus (Figure 8I-L).
Hyperosmolarity  induced  the  disruption  of  F-actin
cytoskeleton, the decrease of several elongated bundles, and
the  disappearance  of  a  ring-like  structure  (Figure  9)  and
altered cell morphology in a time-dependent manner until cell
death. These morphological changes were all observed when
conjunctival cells were stressed for 24 h with BAK or with
combinations  of  hyperosmolarity  with  BAK.  The  F-actin
cytoskeleton  was  severely  disrupted,  leading  to  cell
detachment and death.
DISCUSSION
This  study  simulated  various  conditions  encountered  by
patients  having  dry  eye  by  studying  the  effects  of
hyperosmotic stress, separately or in combination with BAK,
a commonly used eyedrop preservative, to test the hypothesis
that  BAK  administered  in  an  eye  already  submitted  to
hyperosmolar  conditions  would  be  more  toxic  than  in  a
healthy,  normal  ocular  surface.  We  therefore  investigated
conjunctival cell survival, apoptosis, and oxidative stress in
these two conditions because BAK, whose cytotoxicity has
been largely demonstrated [33], is still used in many multidose
eye  drops,  such  as  antiglaucoma  treatments,  antiallergic
agents, or tear substitutes.
We used NaCl to obtain hyperosmolarity ranging from
430  to  500  mOsM,  corresponding  to  high  osmolarities
compared to normal tear osmolarity (300.8±7.80 mOsM) or
even  dry  eye  tear  osmolarity  (343±32  mOsM)  [45,46]  to
evaluate  the  cytotoxic  effects  of  osmotic  stress.  These
osmolarities  were  chosen  because  our  first  attempts  with
lower hyperosmolar media did not reduce cell viability nor
did it induce measurable cell changes in our experimental
conditions (data not shown). We followed the experiments
described by Li et al. [17,18], who had already established that
their findings were obtained at an osmolarity of at least 400
mOsM in human corneal or limbal epithelial cells and argued
in  favor  of  greater  resistance  of  epithelial  cells  to
hyperosmolar  stress  in  vitro  than  in  vivo  [18].  Lower
osmolarities in vivo may be sufficient to compromise ocular
surface integrity and function because the stress is sustained
Figure 6. Oxidative stress evaluation/superoxide anion production (hydroethidine assay) at 24 h (gray bars) and 48 h (black bars). The results
expressed as percentages (means±SD) of the 100% of control DMEM and signals emitted by cell population are reported over the neutral red
test as an indication of viable cells. Compared to control, a significant (p<0.001) increase of fluorescence values at 24 h and 48 h was observed
in HO and BAK conditions alone (except for HO50 mM and BAK3.10−4% at 24 h, and BAK10−4% at 24h and 48h). The combination of
any HO with BAK3.10−4% or BAK5.10−4% induced a superoxide anion increase (p<0.001). The following letter codes were used for
statistical comparisons with (b) all BAK concentrations, (b1) BAK10−4%, (b3) BAK5.10−4%, (b5) BAK3.10−4%, (h) all HO solutions, (h50)
HO50 mM, (h60) HO60 mM, (h90) HO90 mM, corresponding to a statistically significant difference at p<0.001.
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857whereas in vitro higher osmolarities were needed since the
stress  was  only  short-term.  Moreover,  in  vitro  corneal
epithelial cells were shown to adapt to a chronic hypertonic
challenge with animal species differences like between rabbit
and human corneal epithelial cells. This adaptation occurs
through the upregulation of some membrane cotransporter
activity  involved  in  the  regulatory  volume  increase  in
response to hyperosmolar challenges [47].
We  tested  three  BAK  concentrations  from  10−4%  to
5.10−4%. BAK10−4% corresponds to the 1/100 dilution of the
0.01%  concentration  found  in  most  eyedrops  and  to  a
noncytotoxic BAK concentration, as previously reported in
similar  in  vitro  models  [28,29,48,49].  BAK3.10−4%  and
BAK5.10−4%  were  chosen  here  to  evaluate  the  impact  of
cytotoxic BAK concentrations, giving, respectively, 50% and
80% cell death as assessed with the CV assay. As BAK10−4%
and BAK5.10−4% displayed extreme cytotoxic effects from
very mild to very strong, respectively, we observed the most
relevant findings with the intermediate BAK concentration of
3.10−4%.
Conjunctival  epithelial  cells  were  sensitive  to
hyperosmolarity in an osmolarity-dependent manner, but low
hyperosmolarity caused limited changes, showing a relative
capacity of cells to adapt to hyperosmolar conditions. Under
higher hyperosmolar stress or associated toxic factors such as
BAK,  cells  degenerated  through  an  apoptotic  mechanism
associated  with  oxidative  stress.  Hyperosmolarity  also
induced  a  time-  and  dose-dependent  increase  of  PMP.
Interestingly, we observed additive cytotoxic effects of BAK
and HO. For example, when added to cells submitted to HO90
mM, the lowest BAK concentration became highly cytotoxic.
The  intermediate  concentration,  BAK3.10−4%,  exhibited
increased  toxic  effects  with  all  hyperosmolar  solutions,
compared  to  a  normal  osmolarity  condition,  showing
hyperosmolarity-dependent cytotoxicity.
BAK is known as an inducer of oxidative stress and
hyperosmolarity was also shown in some in vitro [50] and in
vivo [51] models to induce ROS; we wanted to investigate the
effects  of  the  association  of  both  stresses  on  the  ROS
production.  Oxidative  stress  was  induced  by  the  two
experimental  stress  conditions.  Hyperosmolar  conditions
moderately  increased  superoxide  anion  production  in  an
osmotic-dependent  manner.  This  production  appeared
efficiently compensated as no further ROS production was
detected  by  the  H2DCFDA  assay  showing  preserved  cell
detoxification  capacities  at  these  levels  of  cytotoxicity
through detoxifying enzymes such as superoxide dismutase,
catalase, or glutathione-peroxidase. BAK is known to impair
such protective mechanisms [28], and these data confirmed
that  it  induced  a  time-  and  dose-dependent  increase  in
superoxide anion and ROS detection. When the two stresses
were combined, BAK seemed to greatly impact the oxidative
responses and hyperosmolarity.
We  also  confirmed  the  involvement  of  two  major
apoptotic pathways, a caspase-dependent one, characterized
by cytochrome c release from the mitochondria to cytoplasm
and  presence  of  the  active  caspase-3  and  a  caspase-
independent one through the translocation of AIF from the
mitochondria to the nucleus where AIF binds to DNA and
leads to chromatin condensation and cell death [52,53]. Here,
Figure 7. Oxidative stress evaluation/reactive oxygen species (COO-, ONOO-) and mainly hydrogen peroxide production (H2DCF-DA assay)
at 24 h (gray bars) and 48 h (black bars). The results expressed as percentages (means±SD) of the 100% of control DMEM and signals emitted
by cell population are reported over the neutral red test as an indication of viable cells. At 24 h and 48 h, compared to control, incubation in
BAK5.10−4% and  combinations of any HO with BAK3.10−4% and BAK5.10−4% induced a superoxide anion increase (p<0.001), except
for HO50 mM and HO60 mM associated with BAK3.10−4% at 24 h. The following letter codes were used for statistical comparisons with
(b) all BAK concentrations, (b1) BAK10−4%, (b3) BAK5.10−4%, (b5) BAK3.10−4%, (h) all HO solutions, (h50) HO50 mM, (h60) HO60
mM, (h90) HO90 mM, corresponding to a statistically significant difference at p<0.001.
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858Figure 8. Immunofluorescence of cytochrome c (A, B, C, D), active caspase-3 (E, F, G, H), and AIF (I, J, K, L). Specific stainings appear
in green. Nuclear staining was assessed with DAPI (blue) and F-actin cytoskeleton staining with Alexa Fluor-546 phalloidin (red). Cells were
stained after 24 h of stress: control cells (A, E, I), HO90 mM (B, F, J), BAK3.10−4% (C, G, K), and the combination of both, HO90 mM
+BAK3.10−4% (D, H, L). Cells after HO90 mM stress (B) induced a release of cytochrome c from mitochondria (dotted staining) to cytoplasm
(diffuse staining) with cytoplasm shrinkage and nuclear condensation after BAK3.10−4% (C) and HO90 mM+BAK3.10−4% (D) compare to
DMEM control (A). Note the intense retraction and almost complete destruction of cells submitted to BAK in the two conditions. Increase of
caspase-3 fluorescence staining observed in the cytoplasm of HO90 mM-stressed cells (F) compared to DMEM (E); BAK3.10−4% (G)
increased caspase-3 in only a few cells; and HO90 mM+BAK3.10−4% (H) induced an increase in all stressed cells. AIF was translocated
from  the  mitochondria,  appearing  as  dotted  staining  for  DMEM  control  (I),  to  the  nucleus  (nuclear  staining)  under  HO90  mM  (J),
BAK3.10−4% (K) and HO90 mM+BAK3.10−4% (L).
Molecular Vision 2012; 18:851-863 <http://www.molvis.org/molvis/v18/a90> © 2012 Molecular Vision
859apoptosis  induced  by  hyperosmolarity  was  found  to  have
comparable mechanisms to that induced by BAK, which has
largely been shown to be proapoptotic on conjunctival cells
[28,29,43,48,49].  These  two  activation  pathways  can  be
executed independently or in parallel. Both were involved in
hyperosmotic  stress,  BAK  toxicity,  and  hyperosmolarity
associated with BAK. Furthermore, cell detachment, F-actin
disorganization,  chromatin  condensation,  and  abnormal
membrane permeability were all found following apoptosis
after hyperosmolar or BAK stresses in our study.
These results support the hypothesis and the frequent
clinical observation that BAK, as a preservative contained in
many eyedrops, when administered to a patient having dry
eye, could dramatically affect conjunctival cells and maintain
or  aggravate  ocular  surface  impairment.  This  model  is  a
simple,  reproducible  in  vitro  model  of  NaCl-induced
hyperosmolarity on a widely used conjunctival cell line, as
already used in similar corneal models [16,17,19,22]. We
acknowledge the limitation that this in vitro model cannot
fully reflect what occurs in patients, as it is based on only one
cell type, exempt of tear film, blood vessels, goblet cells,
immune  cells,  or  air  flow  that  interact  in  complex
multifactorial mechanisms [54-58]. To make in vitro culture
system closer to in vivo ocular surface dry eye disease, some
devices  were  developed  that  allow  cell  exposure  to  a
controlled air flow [58]. Further comparative experimentation
with  such  models  would  be  interesting  in  future  studies.
Nevertheless, the conjunctival epithelium remains useful for
studying the ocular surface, as it was shown to react to dry eye
conditions and cytotoxic stress via expression of HLA DR
[59]  or  secretion  of  proinflammatory  mediators,  such  as
adhesion  molecules  and  chemokines,  and  to  actively
participate in disease pathophysiology [60-62].
In conclusion, both hyperosmolarity and BAK induce
apoptosis  via  similar  mechanisms,  involving  caspase-
dependent and -independent pathways but with a much higher
resistance  to  hyperosmolarity  than  to  toxic  stress.  The
noteworthy findings of this study are that the combination of
a noncytotoxic challenge (hyperosmolarity) and a subtoxic
stress (low preservative concentration) can induce substantial
cell alterations and cell death, much greater than after each
separated stress. This is important from a toxicology point of
view, and this model could be valuable for testing the effects
of many other non- or minimally cytotoxic compounds such
as  environmental  pollutants  or  xenobiotics,  alone  or  in
combination with a condition mimicking dry eye. Concerning
ocular surface diseases, this study highlights the importance
of  avoiding  preservatives  like  BAK  even  at  low
concentrations in a dry eye patient because cytotoxic effects
of BAK will act synergistically with hyperosmolarity.
More broadly, the extensive use of BAK over the long-
term,  as  in  glaucoma,  may  progressively  cause  tear  film
instability  that  will  enhance  hyperosmolarity-induced
responses. They were recently reported to increase in several
BAK-containing medications [39]. Hence, BAK may cause a
condition that will make the ocular surface more sensitive to
the toxic compound itself, initiating an exponential toxicity.
This could explain the high prevalence of dry eye observed in
glaucomatous patients, with a clear relationship between dry
eye  symptoms  and  signs,  the  number  of  medications  and
duration of treatments [35,37,38]. In dry eye, tear substitutes
preserved with BAK may thus induce a vicious cycle, as BAK
Figure 9. Phalloidin staining (magnification 400×) showing the disorganization of F-actin cytoskeleton in HO90 mM condition (B) compared
to DMEM control (A). BAK10−4%-stress (C), BAK3.10−4% (D), and BAK5.10−4% (E) induced cell blebs, cytoplasm shrinkage, and cell
detachment in a dose-dependent manner. All BAK concentrations induced more disorganization and cell shrinkage than even the highest
hyperosmolar stress. Combinations of both stresses, namely HO90 mM+BAK10−4% (F), HO90 mM+BAK3.10−4% (G), and HO90 mM
+BAK5.10−4% (H) deeply altered cell morphology, such as cytoplasm retraction associated with cell-size decrease (large arrows), and induced
a dose-dependent cell death characterized by the presence of apoptotic bodies (thin arrows).
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860may  aggravate  the  consequences  of  hyperosmotic  stress,
enhancing ocular surface impairment, and further requiring
additional tear substitution. Our in vitro model emphasizes the
importance of avoiding BAK in dry eye conditions and for all
chronic  uses,  especially  in  high-risk  patients,  those  with
impaired tear film and ocular surface.
ACKNOWLEDGMENTS
This work was funded by a CIFRE (Convention Industrielle
de  Formation  par  la  Recherche)  grant  from  ANRT
(Association Nationale de la Recherche et de la Technologie)
and Horus Pharma.
REFERENCES
1. The definition and classification of dry eye disease: report of
the  Definition  and  Classification  Subcommittee  of  the
International Dry Eye WorkShop (2007). Ocul Surf 2007;
5:75-92. [PMID: 17508116]
2. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix
C, Feuer W, Reis BL. Evaluation of subjective assessments
and  objective  diagnostic  tests  for  diagnosing  tear-film
disorders  known  to  cause  ocular  irritation.  Cornea  1998;
17:38-56. [PMID: 9436879]
3. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional
visual acuity of dry eye patients. Am J Ophthalmol 2002;
133:181-6. [PMID: 11812420]
4. Miljanović B, Dana R, Sullivan DA, Schaumberg DA. Impact
of dry eye syndrome on vision-related quality of life. Am J
Ophthalmol 2007; 143:409-15. [PMID: 17317388]
5. Baudouin  C.  A  new  approach  for  better  comprehension  of
diseases  of  the  ocular  surface.  J  Fr  Ophtalmol  2007;
30:239-46. [PMID: 17417148]
6. Barabino S, Dana MR. Animal models of dry eye: a critical
assessment  of  opportunities  and  limitations.  Invest
Ophthalmol Vis Sci 2004; 45:1641-6. [PMID: 15161821]
7. Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC.
Apoptosis of ocular surface cells in experimentally induced
dry eye. Invest Ophthalmol Vis Sci 2003; 44:124-9. [PMID:
12506064]
8. Pflugfelder SC, Farley W, Luo L, Chen LZ, De Paiva CS, Olmos
LC, Li DQ, Fini ME. Matrix metalloproteinase-9 knockout
confers resistance to corneal epithelial barrier disruption in
experimental dry eye. Am J Pathol 2005; 166:61-71. [PMID:
15632000]
9. van  Blokland  SC,  Versnel  MA.  Pathogenesis  of  Sjogren’s
syndrome:  characteristics  of  different  mouse  models  for
autoimmune  exocrinopathy.  Clin  Immunol  2002;
103:111-24. [PMID: 12027416]
10. Toshida  H,  Nguyen  DH,  Beuerman  RW,  Murakami  A.
Evaluation  of  novel  dry  eye  model:  preganglionic
parasympathetic denervation in rabbit. Invest Ophthalmol Vis
Sci 2007; 48:4468-75. [PMID: 17898267]
11. Gilbard JP, Rossi SR, Heyda KG. Tear film and ocular surface
changes after closure of the meibomian gland orifices in the
rabbit. Ophthalmology 1989; 96:1180-6. [PMID: 2797721]
12. Gilbard JP, Rossi SR, Gray KL, Hanninen LA. Natural history
of disease in a rabbit model for keratoconjunctivitis sicca.
Acta Ophthalmol Suppl 1989; 192:95-101. [PMID: 2554662]
13. Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K.
Improvement  of  corneal  barrier  function  by  the  P2Y(2)
agonist INS365 in a rat dry eye model. Invest Ophthalmol Vis
Sci 2001; 42:96-100. [PMID: 11133853]
14. Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R,
Sacchetti M, Aloe L, Bonini S. Efficacy of topical nerve
growth factor treatment in dogs affected by dry eye. Graefes
Arch  Clin  Exp  Ophthalmol  2005;  243:151-5.  [PMID:
15650854]
15. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR.
The controlled-environment chamber: a new mouse model of
dry  eye.  Invest  Ophthalmol  Vis  Sci  2005;  46:2766-71.
[PMID: 16043849]
16. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder
SC.  Regulation  of  MMP-9  production  by  human  corneal
epithelial  cells.  Exp  Eye  Res  2001;  73:449-59.  [PMID:
11825017]
17. Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation
of matrix metalloproteinases by hyperosmolarity via a JNK
pathway in human corneal epithelial cells. Invest Ophthalmol
Vis Sci 2004; 45:4302-11. [PMID: 15557436]
18. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK
and ERK MAP kinases mediate induction of IL-1beta, TNF-
alpha  and  IL-8  following  hyperosmolar  stress  in  human
limbal epithelial cells. Exp Eye Res 2006; 82:588-96. [PMID:
16202406]
19. Narayanan S, Manning J, Proske R, McDermott AM. Effect of
hyperosmolality on beta-defensin gene expression by human
corneal  epithelial  cells.  Cornea  2006;  25:1063-8.  [PMID:
17133055]
20. Chen Z, Tong L, Li Z, Yoon KC, Qi H, Farley W, Li DQ,
Pflugfelder  SC.  Hyperosmolarity-induced  cornification  of
human corneal epithelial cells is regulated by JNK MAPK.
Invest  Ophthalmol  Vis  Sci  2008;  49:539-49.  [PMID:
18234997]
21. Bildin VN, Wang Z, Iserovich P, Reinach PS. Hypertonicity-
induced  p38MAPK  activation  elicits  recovery  of  corneal
epithelial cell volume and layer integrity. J Membr Biol 2003;
193:1-13. [PMID: 12879161]
22. Capó-Aponte JE, Wang Z, Bildin VN, Pokorny KS, Reinach
PS.  Fate  of  hypertonicity-stressed  corneal  epithelial  cells
depends on differential MAPK activation and p38MAPK/Na-
K-2Cl  cotransporter1  interaction.  Exp  Eye  Res  2007;
84:361-72. [PMID: 17140565]
23. Pan  Z,  Wang  Z,  Yang  H,  Zhang  F,  Reinach  PS.  TRPV1
activation  is  required  for  hypertonicity-stimulated
inflammatory cytokine release in human corneal epithelial
cells. Invest Ophthalmol Vis Sci 2011; 52:485-93. [PMID:
20739465]
24. Png E, Samivelu GK, Yeo SH, Chew J, Chaurasia SS, Tong L.
Hyperosmolarity  mediated  mitochondrial  dysfunction
requires transglutaminase-2 in human corneal epithelial cells.
J Cell Physiol 2011; 226:693-9. [PMID: 20717931]
25. Luo  L,  Li  DQ,  Pflugfelder  SC.  Hyperosmolarity-induced
apoptosis in human corneal epithelial cells is mediated by
cytochrome  c  and  MAPK  pathways.  Cornea  2007;
26:452-60. [PMID: 17457195]
26. Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P,
Ye C, Ge J, Wang Z. A rabbit dry eye model induced by
topical medication of a preservative benzalkonium chloride.
Molecular Vision 2012; 18:851-863 <http://www.molvis.org/molvis/v18/a90> © 2012 Molecular Vision
861Invest  Ophthalmol  Vis  Sci  2008;  49:1850-6.  [PMID:
18436819]
27. Lin Z, Liu X, Zhou T, Wang Y, Bai L, He H, Liu Z. A mouse
dry  eye  model  induced  by  topical  administration  of
benzalkonium chloride. Mol Vis 2011; 17:257-64. [PMID:
21283525]
28. Debbasch  C,  Brignole  F,  Pisella  PJ,  Warnet  JM,  Rat  P,
Baudouin  C.  Quaternary  ammoniums  and  other
preservatives’ contribution in oxidative stress and apoptosis
on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001;
42:642-52. [PMID: 11222522]
29. Guenoun  JM,  Baudouin  C,  Rat  P,  Pauly  A,  Warnet  JM,
Brignole-Baudouin F. In vitro comparison of cytoprotective
and  antioxidative  effects  of  latanoprost,  travoprost,  and
bimatoprost on conjunctiva-derived epithelial cells. Invest
Ophthalmol Vis Sci 2005; 46:4594-9. [PMID: 16303954]
30. Liang  H,  Baudouin  C,  Pauly  A,  Brignole-Baudouin  F.
Conjunctival and corneal reactions in rabbits following short-
and  repeated  exposure  to  preservative-free  tafluprost,
commercially available latanoprost and 0.02% benzalkonium
chloride.  Br  J  Ophthalmol  2008;  92:1275-82.  [PMID:
18723745]
31. Pauly  A,  Meloni  M,  Brignole-Baudouin  F,  Warnet  JM,
Baudouin  C.  Multiple  endpoint  analysis  of  the  3D-
reconstituted  corneal  epithelium  after  treatment  with
benzalkonium  chloride:  early  detection  of  toxic  damage.
Invest  Ophthalmol  Vis  Sci  2009;  50:1644-52.  [PMID:
19168896]
32. Baudouin C. Side effects of antiglaucomatous drugs on the
ocular surface. Curr Opin Ophthalmol 1996; 7:80-6. [PMID:
10163327]
33. Rolando M, Terragna F, Giordano G, Calabria G. Conjunctival
surface damage distribution in keratoconjunctivitis sicca. An
impression  cytology  study.  Ophthalmologica  1990;
200:170-6. [PMID: 2367078]
34. Kahook MY, Noecker R. Quantitative analysis of conjunctival
goblet cells after chronic application of topical drops. Adv
Ther 2008; 25:743-51. [PMID: 18670744]
35. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular
surface  disease  in  glaucoma  patients.  J  Glaucoma  2008;
17:350-5. [PMID: 18703943]
36. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin
F. Preservatives in eyedrops: the good, the bad and the ugly.
Prog Retin Eye Res 2010; 29:312-34. [PMID: 20302969]
37. Pisella  PJ,  Pouliquen  P,  Baudouin  C.  Prevalence  of  ocular
symptoms and signs with preserved and preservative free
glaucoma  medication.  Br  J  Ophthalmol  2002;  86:418-23.
[PMID: 11914211]
38. Jaenen N, Baudouin C, Pouliquen P, Manni G, Figueiredo A,
Zeyen T. Ocular symptoms and signs with preserved and
preservative-free glaucoma medications. Eur J Ophthalmol
2007; 17:341-9. [PMID: 17534814]
39. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC,
Jasek MC. Prevalence of ocular surface complaints in patients
with glaucoma using topical intraocular pressure-lowering
medications. Cornea 2010; 29:618-21. [PMID: 20386433]
40. Erb C, Gast U, Schremmer D. German register for glaucoma
patients with dry eye. I. Basic outcome with respect to dry
eye.  Graefes  Arch  Clin  Exp  Ophthalmol  2008;
246:1593-601. [PMID: 18648841]
41. Baudouin C. Detrimental effect of preservatives in eyedrops:
implications for the treatment of glaucoma. Acta Ophthalmol
2008; 86:716-26. [PMID: 18537937]
42. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Tear
film osmolarity in patients treated for glaucoma or ocular
hypertension. Cornea. In press
43. Brasnu  E,  Brignole-Baudouin  F,  Riancho  L,  Warnet  JM,
Baudouin C. Comparative study on the cytotoxic effects of
benzalkonium chloride on the Wong-Kilbourne derivative of
Chang conjunctival and IOBA-NHC cell lines. Mol Vis 2008;
14:394-402. [PMID: 18334956]
44. Di  Virgilio  F.  The  P2Z  purinoceptor:  an  intriguing  role  in
immunity,  inflammation  and  cell  death.  Immunol  Today
1995; 16:524-8. [PMID: 7495489]
45. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear
microvolumes  in  keratoconjunctivitis  sicca.  Arch
Ophthalmol 1978; 96:677-81. [PMID: 646697]
46. Lemp MA, Bron AJ, Baudouin C, Benitez Del Castillo JM,
Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Tear
osmolarity  in  the  diagnosis  and  management  of  dry  eye
disease.  Am  J  Ophthalmol  2011;  151:792-8.  [PMID:
21310379]
47. Bildin  VN,  Yang  H,  Crook  RB,  Fischbarg  J,  Reinach  PS.
Adaptation by corneal epithelial cells to chronic hypertonic
stress depends on upregulation of Na:K:2Cl cotransporter
gene  and  protein  expression  and  ion  transport  activity.  J
Membr Biol 2000; 177:41-50. [PMID: 10960152]
48. Brasnu  E,  Brignole-Baudouin  F,  Riancho  L,  Guenoun  JM,
Warnet JM, Baudouin C. In vitro effects of preservative-free
tafluprost  and  preserved  latanoprost,  travoprost,  and
bimatoprost in a conjunctival epithelial cell line. Curr Eye Res
2008; 33:303-12. [PMID: 18398704]
49. Reinehr R, Häussinger D. Hyperosmotic activation of the CD95
system.  Methods  Enzymol  2007;  428:145-60.  [PMID:
17875416]
50. St-Louis  R,  Parmentier  C,  Raison  D,  Grange-Messent  V,
Hardin-Pouzet H. Reactive oxygen species are required for
the hypothalamic osmoregulatory response. Endocrinology
2012; 153:1317-29. [PMID: 22202167]
51. De  Saint  Jean  M,  Brignole  F,  Bringuier  AF,  Bauchet  A,
Feldmann G, Baudouin C. Effects of benzalkonium chloride
on growth and survival of Chang conjunctival cells. Invest
Ophthalmol Vis Sci 1999; 40:619-30. [PMID: 10067965]
52. Susin  SA,  Lorenzo  HK,  Zamzami  N,  Marzo  I,  Snow  BE,
Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M,
Larochette N, Goodlett DR, Aebersold R, Siderovski DP,
Penninger  JM,  Kroemer  G.  Molecular  characterization  of
mitochondrial  apoptosis-inducing  factor.  Nature  1999;
397:441-6. [PMID: 9989411]
53. Lorenzo HK, Susin SA, Penninger J, Kroemer G. Apoptosis
inducing  factor  (AIF):  a  phylogenetically  old,  caspase-
independent effector of cell death. Cell Death Differ 1999;
6:516-24. [PMID: 10381654]
54. Stern  ME,  Beuerman  RW,  Fox  RI,  Gao  J,  Mircheff  AK,
Pflugfelder SC. The pathology of dry eye: the interaction
between the ocular surface and lacrimal glands. Cornea 1998;
17:584-9. [PMID: 9820935]
55. Stern  ME,  Beuerman  RW,  Fox  RI,  Gao  J,  Mircheff  AK,
Pflugfelder SC. A unified theory of the role of the ocular
Molecular Vision 2012; 18:851-863 <http://www.molvis.org/molvis/v18/a90> © 2012 Molecular Vision
862surface in dry eye. Adv Exp Med Biol 1998; 438:643-51.
[PMID: 9634949]
56. Pflugfelder  SC,  Solomon  A,  Stern  M.  The  diagnosis  and
management of dry eye: a twenty-five-year review. Cornea
2000; 19:644-9. [PMID: 11009316]
57. Barabino S, Dana MR. Dry eye syndromes. Chem Immunol
Allergy 2007; 92:176-84. [PMID: 17264493]
58. Paulsen K, Maile S, Giebel J, Tost FH. Lubricating agents differ
in their protection of cultured human epithelial cells against
desiccation.  Med  Sci  Monit  2008;  14:PI12-6.  [PMID:
18509283]
59. Versura P, Profazio V, Schiavi C, Campos EC. Hyperosmolar
Stress  Upregulates  HLA-DR  Expression  in  Human
Conjunctival Epithelium in Dry Eye Patients and In Vitro
Models.  Invest  Ophthalmol  Vis  Sci  2011;  52:5488-96.
[PMID: 21498621]
60. Jones  DT,  Monroy  D,  Ji  Z,  Atherton  SS,  Pflugfelder  SC.
Sjogren's syndrome: cytokine and Epstein-Barr viral gene
expression  within  the  conjunctival  epithelium.  Invest
Ophthalmol Vis Sci 1994; 35:3493-504. [PMID: 8056525]
61. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel
A, Baudouin C. Flow cytometric analysis of inflammatory
markers in conjunctival epithelial cells in patients with dry
eyes. Invest Ophthalmol Vis Sci 2000; 41:1356-63. [PMID:
10798650]
62. Brignole F, Pisella PJ, De Saint Jean M, Goldschild M, Goguel
A, Baudouin C. Flow cytometric analysis of inflammatory
markers in KCS: 6-month treatment with topical cyclosporin
A.  Invest  Ophthalmol  Vis  Sci  2001;  42:90-5.  [PMID:
11133852]
Molecular Vision 2012; 18:851-863 <http://www.molvis.org/molvis/v18/a90> © 2012 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 7 April 2012. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
863